BluGlass CEO Jim Haden presented at the Automic Invest Conference, and provided an update on the Company’s business momentum, recent contract wins, and market focus.
Some key takeaways:
– The critical role GaN lasers play in quantum sensing, defence, next-generation computing, and biotech markets
– How BluGlass’ unique technology capabilities positions us as a partner of choice in a rapidly growing markets
– Record business momentum in FY24, and gaining momentum in FY25 with over $6M in recent contract wins
– An exciting pipeline for FY25, including US Department of Defense contracts and strategic partnerships
The interview is available to stream here: https://lnkd.in/gVkiMXri
About BluGlass
Developing leading-edge semiconductor manufacturing technology and devices for more than a decade, BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.
Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the USA offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.
The Company combines its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing process with advanced device design and fabrication to deliver differentiated laser solutions. With end-to-end capabilities spanning epitaxy, device design, fabrication, and testing, BluGlass is well-positioned to support critical next-generation photonics applications and sovereign supply chains.
For more information, please contact:
Stefanie Winwood
+61293342300 |swinwood@bluglass.com
James Lennon, Automic Markets
+61414035704 |james.lennon@automicgroup.com.au
Samuel Samhan, BluGlass CFO
ssamhan@bluglass.com
